Haleon
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 2022-01-01
- Employees
- 25.4K
- Market Cap
- -
- Website
- http://www.haleon.com
- Introduction
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
Clinical Study to Investigate the Ability of a Stannous Fluoride Toothpaste to Protect From Dentine Hypersensitivity
- Conditions
- Dentin Sensitivity
- Interventions
- Drug: Sensodyne Rapid ReliefDrug: Colgate Cavity Protection
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- HALEON
- Target Recruit Count
- 80
- Registration Number
- NCT06733285
- Locations
- 🇬🇧
University of Bristol, Bristol Dental School and Hospital, Bristol, United Kingdom
A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
- Conditions
- Common ColdCough
- Interventions
- Drug: Robitussin Maximum Strength Cough and Chest Congestion DMDrug: Robitussin Maximum Strength Nighttime Cough DM
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- HALEON
- Target Recruit Count
- 260
- Registration Number
- NCT06716645
- Locations
- 🇺🇸
Lindus Health Limited, New York, New York, United States
A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
- Conditions
- Dental PlaqueGingivitis
- Interventions
- Drug: Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)Drug: Regular Fluoride Toothpaste (Crest Cavity Protection)Drug: CPC Mouthwash (Parodontax Active Gum Health Mouthwash)
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- HALEON
- Target Recruit Count
- 198
- Registration Number
- NCT06660069
- Locations
- 🇺🇸
Salus Research, Fort Wayne, Indiana, United States
A Study Evaluating Quality of Life Parameters Following Use of Emergen-C
- Conditions
- Dietary Supplements
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- HALEON
- Target Recruit Count
- 299
- Registration Number
- NCT06654089
- Locations
- 🇬🇧
Lindus Health Limited, London, England, United Kingdom
A Clinical Study Assessing the Effects of a Marketed Dentifrice on Tooth Sensitivity While Undergoing Tooth Bleaching
- Conditions
- Dentin Sensitivity
- Interventions
- Drug: Test Dentifrice (Sensodyne Repair and Protect Original Mint)Drug: Positive Control Dentifrice (Sensodyne Fresh Mint)Drug: Reference Dentifrice (Crest Cavity Protection Regular)
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- HALEON
- Target Recruit Count
- 90
- Registration Number
- NCT06608368
- Locations
- 🇨🇦
All Sum Research, Mississauga, Ontario, Canada
A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health
- Conditions
- Dental PlaqueGingivitis
- Interventions
- Drug: Test toothpasteDrug: Colgate Cavity Protection Toothpaste
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- HALEON
- Target Recruit Count
- 161
- Registration Number
- NCT06602466
- Locations
- 🇬🇧
Birmingham University Dental School, Birmingham, United Kingdom
A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- HALEON
- Target Recruit Count
- 196
- Registration Number
- NCT06379893
- Locations
- 🇵🇱
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp z .o.o, Malbork, Poland
🇵🇱Specjalistyczny Osrodek Lecziczo Badawczy (SOLB) Zbgniew Żęgota, Ostróda, Poland
🇵🇱Santa Sp. z o.o. Santa Familia PTG Lodz, Łódź, Poland
A Clinical Study to Evaluate the Anti-Sensitivity Effect of a Calcium Sodium Phosphosilicate Toothpaste in a Population of Dentin Hypersensitivity Sufferers
- Conditions
- Dentin Sensitivity
- Interventions
- Drug: CSPS toothpasteDrug: Regular fluoride toothpaste (Crest Cavity Protection)
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- HALEON
- Target Recruit Count
- 217
- Registration Number
- NCT06378008
- Locations
- 🇨🇦
All Sum Research, Mississauga, Ontario, Canada
Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers
- Conditions
- Dentin Sensitivity
- Interventions
- Drug: Stannous fluoride toothpasteDrug: Crest cavity protection toothpaste
- First Posted Date
- 2024-04-11
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- HALEON
- Target Recruit Count
- 111
- Registration Number
- NCT06359028
- Locations
- 🇺🇸
Salus Research, Fort Wayne, Indiana, United States
A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers
- Conditions
- Dentin Sensitivity
- Interventions
- Drug: Stannous fluoride toothpasteDrug: Regular fluoride toothpaste (Crest Cavity Protection)
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- HALEON
- Target Recruit Count
- 115
- Registration Number
- NCT06354270
- Locations
- 🇺🇸
Family and Cosmetic Dentistry, All Sums Research Center Ltd., Melbourne, Florida, United States